Table 2 Basal characteristics, echocardiographic results, and RV 2DSTE of the two groups
Group 1 (N = 100) (patients with osteosarcoma) | Group 2 (N = 100) (control group) | P value | |
|---|---|---|---|
Age, years | 11.85 ± 2.09 | 12.13 ± 1.87 | 0.320 |
Male gender, n (%) | 50 (50.0%) | 52 (52.0%) | 0.777 |
BSA, m2 | 1.39 ± 0.07 | 1.40 ± 0.08 | 0.394 |
IVS, cm | 0.49 ± 0.07 | 0.50 ± 0.08 | 0.571 |
PW, cm | 0.50 ± 0.08 | 0.51 ± 0.09 | 0.320 |
LVEDD, cm | 3.60 ± 0.30 | 3.65 ± 0.28 | 0.211 |
LVESD, cm | 1.71 ± 0.32 | 1.69 ± 0.31 | 0.687 |
LVEF, % | 67.7 ± 3.62 | 68.2 ± 3.52 | 0.353 |
LVGLS, % | − 23.77 ± 0.93 | − 23.83 ± 0.91 | 0.670 |
LA diameter, cm | 1.89 ± 0.21 | 1.85 ± 0.22 | 0.237 |
AO, cm | 1.90 ± 0.18 | 1.87 ± 0.20 | 0.196 |
RVGLS, % | − 24.75 ± 0.53 | − 24.64 ± 0.35 | 0.110 |
Apical RVS, % | − 24.91 ± 0.72 | − 24.87 ± 0.66 | 0.684 |
Mid RVS, % | − 24.16 ± 0.64 | − 24.11 ± 0.53 | 0.472 |
Basal RVS, % | − 24.65 ± 1.05 | − 24.45 ± 0.92 | 0.172 |
RVS, cm/s | 13.80 ± 0.66 | 13.79 ± 0.64 | 0.940 |
RVE, cm/s | 13.61 ± 0.48 | 13.55 ± 0.49 | 0.455 |
RVA, cm/s | 12.00 ± 0.57 | 11.92 ± 0.58 | 0.297 |
Tapse, cm | 1.87 ± 0.15 | 1.88 ± 0.15 | 0.679 |
FAC, % | 35.80 ± 1.03 | 35.79 ± 1.06 | 0.946 |